[
  {
    "ts": null,
    "headline": "3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List",
    "summary": "The best healthcare stocks from Goldman Sachs' list that are also Quant Strong Buys have attractive valuations and forward earnings growth potential. Click here to see the top 3 stocks.",
    "url": "https://finnhub.io/api/news?id=74c02aacfdcf6b179b4f6d9ada5443e306b4c5674ecc95adbf719a39d4ecc8ed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763395539,
      "headline": "3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List",
      "id": 137508603,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2197655235/image_2197655235.jpg?io=getty-c-w1536",
      "related": "INCY",
      "source": "SeekingAlpha",
      "summary": "The best healthcare stocks from Goldman Sachs' list that are also Quant Strong Buys have attractive valuations and forward earnings growth potential. Click here to see the top 3 stocks.",
      "url": "https://finnhub.io/api/news?id=74c02aacfdcf6b179b4f6d9ada5443e306b4c5674ecc95adbf719a39d4ecc8ed"
    }
  },
  {
    "ts": null,
    "headline": "Incyte Announces Positive CHMP Opinion for Minjuvi速 (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)",
    "summary": "MORGES, Switzerland, November 17, 2025--Incyte Announces Positive CHMP Opinion for Minjuvi速 (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)",
    "url": "https://finnhub.io/api/news?id=58050c3e72d8ea7a2ac07e62b0854eee8931866ee3a4acac81638079dcef5c12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763359200,
      "headline": "Incyte Announces Positive CHMP Opinion for Minjuvi速 (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)",
      "id": 137504379,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "MORGES, Switzerland, November 17, 2025--Incyte Announces Positive CHMP Opinion for Minjuvi速 (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)",
      "url": "https://finnhub.io/api/news?id=58050c3e72d8ea7a2ac07e62b0854eee8931866ee3a4acac81638079dcef5c12"
    }
  }
]